deoxyglucose has been researched along with Cancer of Ovary in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.56) | 18.7374 |
1990's | 15 (41.67) | 18.2507 |
2000's | 5 (13.89) | 29.6817 |
2010's | 13 (36.11) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Chen, XS; Cheng, Y; Li, LY; Tian, M; Wang, XL; Wu, HZ; Xiao, SS; Zeng, D; Zhang, Y | 1 |
Allo, G; Carey, MS; Chhina, J; Dai, J; Giri, S; Llaurado, M; Mert, I; Munkarah, AR; Rattan, R; Seward, S | 1 |
Deng, X; Gao, W; Liu, Y; Su, J; Sun, L; Wu, S; Xie, L; Xu, Y; Yang, J; Yu, H; Zhang, Y | 1 |
Brenneman, R; Kurtoglu, M; Lampidis, TJ; Liu, H; Sullivan, EJ | 1 |
Bannai, T; Ohtomo, R; Sawamura, H; Tsuji, S; Wakakura, M; Yamamoto, T | 1 |
Alvero, AB; Graham, E; Joo, WD; Montagna, MK; Mor, G; Sumi, NJ | 1 |
Baker, AF; Carbajal, L; Gill, A; Hanke, NT; Malm, SW | 1 |
Morís, F; Núñez, LE; Portugal, J; Rodríguez-Sánchez, MA; Vizcaíno, C | 1 |
Li, S; Liu, S; Su, J; Wang, Y; Xie, Q; Xu, Y; Yi, D; Yu, Y; Zeng, L; Zhang, L | 1 |
Binz, L; Faber, D; Fabian, CG; Goetze, K; Indraccolo, S; Mueller-Klieser, W; Nardo, G; Sattler, UG; Siebers, A | 1 |
Baudy, AR; Daemen, A; Evangelista, M; Gao, M; Haley, B; Hatzivassiliou, G; Pusapati, RV; Sandoval, W; Settleman, J; Wilson, C | 1 |
Avall-Lundqvist, E; Hernlund, E; Hjerpe, E; Shoshan, M | 1 |
Gossner, G; Griffith, K; Kshirsagar, M; Liu, JR; Loar, P; Wahl, H | 1 |
He, G; Kueck, A; Kwok, R; Liu, JR; Opipari, A; Priebe, A; Tan, L; Wahl, H | 1 |
Emons, G; Gründker, C; Reutter, M | 1 |
Choi, M; Fogoros, S; Gossner, G; Griffith, KA; Kuenker, M; Liu, JR; Tan, L | 1 |
Choi, M; Griffith, KA; Huang, J; Kueck, A; Liu, JR; Opipari, AW; Tan, L; Wahl, H | 1 |
Ball, D; Bohdiewicz, PJ; Dworkin, H; Juni, JE | 1 |
Brown, RS; Clavo, AC; Wahl, RL | 1 |
Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F | 1 |
Cane, P; Glaspy, J; Hawkins, R; Hoh, C; Karlan, BY; Lee, M; Tse, N | 1 |
Buonocore, E; Gould, HR; Hubner, KF; McDonald, TW; Niethammer, JG; Smith, GT | 1 |
Brown, RS; Fisher, SJ; Wahl, RL | 1 |
Clavo, AC; Higashi, K; Wahl, RL | 2 |
Clavo, AC; Wahl, RL | 1 |
Alavi, A; Goldenberg, DM; Hanley, D; Herskovic, T; Juweid, M; Pereira, M; Rubin, AD; Sharkey, RM; Swayne, LC | 1 |
Avril, N; Dose, J; Herz, M; Jänicke, F; Kuhn, W; Römer, W; Schwaiger, M; Ziegler, S | 1 |
Clavo, AC; Torizuka, T; Wahl, RL | 1 |
Arienti, F; Bogni, A; Bombardieri, E; Botti, C; Canevari, S; Crippa, F; Lombardo, C; Maffioli, L; Massaron, S; Negri, DR; Nerini-Molteni, S; Pascali, C; Ramakrishna, V; Remonti, F; Seregni, E | 1 |
Liu, RS; Ng, HT; Wang, PH; Yeh, SH; Yuan, CC | 1 |
Fujibayashi, Y; Murata, T; Omata, N; Sadato, N; Takahashi, N; Waki, A; Welch, MJ; Yonekura, Y; Yoshimoto, M | 1 |
Cailleux, N; Colombet-Lamau, C; de Beco, V; Grahek, D; Kerrou, K; Montravers, F; Petegnief, Y; Talbot, JN; Younsi, N | 1 |
Kangas, L; Knuutila, V; Minn, H; Paul, R; Sipilä, H | 1 |
Hughes, CS; Shen, JW; Subjeck, JR | 1 |
Jimbo, T; Kaibara, M; Ogino, M; Okinaga, S; Tanaka, K | 1 |
1 review(s) available for deoxyglucose and Cancer of Ovary
Article | Year |
---|---|
[(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers].
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
1 trial(s) available for deoxyglucose and Cancer of Ovary
Article | Year |
---|---|
Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
Topics: Adolescent; Adult; Aged; Deoxyglucose; Evaluation Studies as Topic; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Pilot Projects; Tomography, Emission-Computed | 1993 |
34 other study(ies) available for deoxyglucose and Cancer of Ovary
Article | Year |
---|---|
Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
Topics: Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Glycolysis; HEK293 Cells; Humans; Mice, Nude; Ovarian Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Xenograft Model Antitumor Assays | 2021 |
Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer.
Topics: AMP-Activated Protein Kinases; Antimetabolites; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Metformin; Neoplasm Grading; Neoplasms, Cystic, Mucinous, and Serous; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; ras Proteins; Signal Transduction | 2017 |
ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Topics: Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Female; Glucose; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitochondria; Nitrophenols; Ovarian Neoplasms; Oxidative Phosphorylation; Piperazines; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Sulfonamides | 2018 |
Targeting cisplatin-resistant human tumor cells with metabolic inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Female; Glycolysis; Hexokinase; Humans; Lactic Acid; Lung Neoplasms; Ovarian Neoplasms; RNA, Small Interfering; Transfection | 2014 |
Anti-NMDA receptor encephalitis associated with transient cerebral dyschromatopsia, prosopagnosia, and lack of stereopsis.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Cerebral Cortex; Deoxyglucose; Depth Perception; Female; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Perceptual Disorders; Positron-Emission Tomography; Prosopagnosia; Teratoma; Young Adult | 2014 |
Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Deoxyglucose; Electron Transport Chain Complex Proteins; Female; Glycolysis; Humans; Hyaluronan Receptors; I-kappa B Kinase; Maintenance Chemotherapy; Mice; Mitochondria; Molecular Targeted Therapy; Myeloid Differentiation Factor 88; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Ovarian Neoplasms; Oxidative Phosphorylation; Paclitaxel; Phenotype; RNA Interference; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Female; Genes, Reporter; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Lactic Acid; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Pyridines; Transcription, Genetic | 2015 |
Cytotoxic effects of mithramycin DIG-MSK can depend on the rise of autophagy.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Colonic Neoplasms; Deoxyglucose; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Plicamycin | 2015 |
2-Deoxy-d-Glucose Sensitizes Human Ovarian Cancer Cells to Cisplatin by Increasing ER Stress and Decreasing ATP Stores in Acidic Vesicles.
Topics: Acids; Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxyglucose; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Humans; Ovarian Neoplasms; Up-Regulation | 2015 |
Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Deoxyglucose; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Gamma Rays; Glucose; Glycolysis; Humans; Mice, SCID; Microscopy, Fluorescence; Ovarian Neoplasms; Oxamic Acid; Oxygen Consumption; Reactive Oxygen Species; Rotenone; Xenograft Model Antitumor Assays | 2015 |
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.
Topics: Adenosine Triphosphate; Animals; Carcinoma; Cell Line, Tumor; Citric Acid Cycle; Combined Modality Therapy; Cytokines; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Everolimus; Female; Glucose-6-Phosphate Isomerase; Glutaminase; Glutamine; Glycolysis; Hep G2 Cells; Humans; Mechanistic Target of Rapamycin Complex 1; Metabolomics; Mice; Mice, Nude; Molecular Targeted Therapy; Multiprotein Complexes; Neoplasm Proteins; Neoplasms; Ovarian Neoplasms; Pentose Phosphate Pathway; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2016 |
Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Topics: Antimetabolites; Antineoplastic Agents; Apoptosis; Blotting, Western; Carboplatin; Cell Proliferation; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lactic Acid; Mitochondrial Proton-Translocating ATPases; Ovarian Neoplasms; Tumor Cells, Cultured | 2009 |
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Deoxyglucose; Female; Glucose Transporter Type 1; Glycolysis; Humans; Intracellular Signaling Peptides and Proteins; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Sirolimus; TOR Serine-Threonine Kinases | 2010 |
Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Deoxyglucose; Enzyme Activation; Female; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt | 2011 |
Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cell Line, Tumor; Cell Survival; Deoxyglucose; Drug Evaluation, Preclinical; Drug Synergism; Endometrial Neoplasms; Female; Glycolysis; Humans; Molecular Targeted Therapy; Ovarian Neoplasms; Receptors, LHRH; Starvation; Treatment Outcome | 2013 |
Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Growth Processes; Cell Line, Tumor; Deoxyglucose; Drug Resistance, Neoplasm; Female; Genistein; Humans; Ovarian Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt | 2007 |
Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Autophagy; Caspases; Cell Growth Processes; Cell Line, Tumor; Deoxyglucose; Female; Glucose; Humans; Ovarian Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Tritium | 2007 |
Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Tomography, Emission-Computed | 1995 |
Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.
Topics: Cell Hypoxia; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Immunohistochemistry; Melanoma, Experimental; Monosaccharide Transport Proteins; Ovarian Neoplasms; Oxygen; Tumor Cells, Cultured | 1995 |
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed | 1995 |
Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tomography, Emission-Computed | 1993 |
Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma.
Topics: Animals; Autoradiography; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Radioimmunodetection | 1993 |
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
Topics: Adenocarcinoma; Cell Division; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Ovarian Neoplasms; Thymidine; Tritium; Tumor Cells, Cultured | 1993 |
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Methionine; Ovarian Neoplasms; Thymidine; Time Factors; Tomography, Emission-Computed; Tumor Cells, Cultured | 1993 |
Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells.
Topics: Cell Hypoxia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Leucine; Melanoma; Methionine; Ovarian Neoplasms; Oxygen; Thymidine; Time Factors; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 1996 |
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.
Topics: Aged; Antibodies, Monoclonal; CA-125 Antigen; Carcinoembryonic Antigen; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Ovarian Neoplasms; Radioimmunotherapy; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
[Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose].
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Leucine; Methionine; Ovarian Neoplasms; Thymidine; Tomography, Emission-Computed; Tumor Cells, Cultured | 1997 |
Comparison of three different methods for radiolabelling human activated T lymphocytes.
Topics: Cell Death; Cell Survival; Cells, Cultured; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Isotope Labeling; Lymphocyte Activation; Organometallic Compounds; Organotechnetium Compounds; Ovarian Neoplasms; Oximes; Oxyquinoline; T-Lymphocytes; Technetium Tc 99m Exametazime; Tumor Cells, Cultured | 1997 |
Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
Topics: CA-125 Antigen; Deoxyglucose; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells.
Topics: Acetates; Acetyl Coenzyme A; Carbon Radioisotopes; Cell Division; Colonic Neoplasms; Deoxyglucose; Female; Fibroblasts; Humans; Kinetics; Melanoma; Nose Neoplasms; Ovarian Neoplasms; Tomography, Emission-Computed; Tritium; Tumor Cells, Cultured | 2001 |
Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Survival; Deoxyglucose; Drug Screening Assays, Antitumor; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Leukemia L1210; Luminescent Measurements; Mice; Ovarian Neoplasms; Tumor Cells, Cultured | 1991 |
Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells.
Topics: Animals; Calcimycin; Cricetinae; Cricetulus; Dactinomycin; Deoxyglucose; Doxorubicin; Drug Resistance; Etoposide; Female; HSP70 Heat-Shock Proteins; Hypoxia; Membrane Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine | 1989 |
Small dose of 2-deoxy-D-glucose completely excludes the overgrowth of fibroblasts.
Topics: Adenocarcinoma; Cell Count; Cell Division; Cell Line; Culture Media; Deoxy Sugars; Deoxyglucose; Female; Fibroblasts; Humans; Lung; Ovarian Neoplasms | 1987 |